Visa (V)
(Delayed Data from NYSE)
$307.40 USD
+14.11 (4.81%)
Updated Nov 6, 2024 04:00 PM ET
Pre-Market: $307.32 -0.08 (-0.03%) 9:20 AM ET
2-Buy of 5 2
C Value C Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$307.40 USD
+14.11 (4.81%)
Updated Nov 6, 2024 04:00 PM ET
Pre-Market: $307.32 -0.08 (-0.03%) 9:20 AM ET
2-Buy of 5 2
C Value C Growth D Momentum C VGM
Zacks News
MasterCard (MA) Up 4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MasterCard (MA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
AmEx Stock Rallies 37.2% YTD: Time to Buy, Sell or Hold?
by Zubia Masood
AXP continues to benefit from new card acquisitions, fee growth and improved net interest income.
Affirm Holdings Q4 Loss Narrows Y/Y, GMV Outlook Raised
by Zacks Equity Research
AFRM expects GMV of more than $33.5 billion in fiscal 2025.
3 Fintech Stocks to Buy: AFRM, UPST, PYPL
by Andrew Rocco
New economy fintech and payment stocks exhibit strong growth and bullish prospects. Affirm's bullish earnings report last night should bolster this market segment further into 2025.
The Zacks Analyst Blog Highlights Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical
by Zacks Equity Research
Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical are included in this Analyst Blog.
Visa (V) Stock Moves -0.57%: What You Should Know
by Zacks Equity Research
Visa (V) closed at $269.19 in the latest trading session, marking a -0.57% move from the prior day.
Top Analyst Reports for Linde, AstraZeneca & Walt Disney
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), AstraZeneca PLC (AZN) and The Walt Disney Company (DIS), as well as two micro-cap stocks FitLife Brands, Inc. (FTLF) and Utah Medical Products, Inc. (UTMD).
Should You Invest in the Financial Select Sector SPDR ETF (XLF)?
by Zacks Equity Research
Sector ETF report for XLF
Visa to Enhance Digital Payments With New Advisory Service
by Zacks Equity Research
Continuous addition of such new value-added services helps V to stay in the leading position in the payments landscape.
Should You Invest in the Fidelity MSCI Financials Index ETF (FNCL)?
by Zacks Equity Research
Sector ETF report for FNCL
Top Stock Reports for Texas Instruments, Union Pacific & Vertex Pharmaceuticals
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments Incorporated (TXN), Union Pacific Corporation (UNP) and Vertex Pharmaceuticals Incorporated (VRTX), as well as two micro-cap stocks Tile Shop Holdings, Inc. (TTSH) and Gencor Industries, Inc. (GENC).
Why Is Visa (V) Up 5.5% Since Last Earnings Report?
by Zacks Equity Research
Visa (V) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Visa Inc. (V) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Visa (V) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Affirm (AFRM) Steers BNPL Into Auto Repair With Tekmetric Deal
by Zacks Equity Research
The alliance adds Tekmetric to Affirm's (AFRM) network of 292,000 retail partners.
Affirm (AFRM) Falls 22% in a Month: Should You Buy the Dip?
by Debasmita Chatterjee
While Affirm (AFRM) encounters headwinds such as higher funding costs, its strategic initiatives fetch higher merchant fees that could pave the way for recovery and sustained growth.
How Should You Play Mastercard (MA) Stock Post Q2 Earnings?
by Zubia Masood
Mastercard (MA), being a highly profitable company, keeps boosting its shareholder value, reflecting operating strength.
Investors Heavily Search Visa Inc. (V): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Visa (V). This makes it worthwhile to examine what the stock has in store.
Global Payments (GPN) Q2 Earnings Beat on Transaction Growth
by Zacks Equity Research
Global Payments (GPN) expects EPS between $11.54 and $11.70 in 2024, which implies 11-12% growth from the 2023 figure of $10.42.
Top Stock Reports for Berkshire Hathaway, Tesla & Visa
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Tesla, Inc. (TSLA) and Visa Inc. (V), as well a micro-cap stock AXIL Brands, Inc. (AXIL).
Should You Invest in the iShares U.S. Financial Services ETF (IYG)?
by Zacks Equity Research
Sector ETF report for IYG
Analyzing Visa (V) Q3 Performance: Bullish Buy or Bearish Bye?
by Kaibalya Pravo Dey
Visa (V) is a highly profitable company, and it keeps boosting shareholder value, reflecting its operating strength.
Zacks Investment Ideas feature highlights: Nike and Visa
by Zacks Equity Research
Nike and Visa have been highlighted in this Investment Ideas article.
Western Union (WU) Q2 Earnings Meet, Iraq Results Dismal
by Zacks Equity Research
Western Union's (WU) Q2 results reflect the impacts of foreign currency volatility and Business Solutions divestiture, despite transaction growth in its Branded Digital business and cost-cutting measures.
FOUR or V: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FOUR vs. V: Which Stock Is the Better Value Option?
Can the Paris Olympics Reignite This Beaten Down Stock?
by Derek Lewis
Exposure during the Paris Olympics could provide a boost for Nike, which has suffered in 2024 due to shifting consumer preferences.